
M. tuberculosis (strain ATCC 25177 / H37Ra) Ag85A 187-195, VYAGAMSGL
Description
About M. tuberculosis (strain ATCC 25177 / H37Ra) Ag85A 187-195, VYAGAMSGL
The M. tuberculosis (strain ATCC 25177 / H37Ra) Diacylglycerol acyltransferase/mycolyltransferase Ag85A Peptide (IEDB: 71971) is a high quality epitope peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxicity or proliferation assays. The Diacylglycerol acyltransferase/mycolyltransferase Peptide, H-VYAGAMSGL-OH (Uniprot: A5U3Q3 aa: 187-195) from JPT is produced under strict quality control and quality management.
M. tuberculosis (strain ATCC 25177 / H37Ra) Ag85A 187-195, VYAGAMSGL - Specifications
- Peptide sequence: H-VYAGAMSGL-OH
- Amount: 10 mg (10 x 1 mg)
- Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS)
- Counterion: TFA
- Delivery Format: Freeze-dried in glass vial
- Application(s): T-cell Immunity
- Condition(s)/Topic(s): Infection
- Standard Delivery Time: approx. 3 weeks
JPT’s Antigen Peptides
Find your antigen peptide and select the connected PepMix™ Peptide Pool for efficient immune monitoring, mapping of T cell epitopes or development of immunotherapy and vaccines. JPT Peptide Technologies has substantial, long-standing expertise in providing peptides, peptidomimetics, and proteins to the global scientific community. Our highly skilled and committed scientific staff ensures that the most appropriate methods and techniques are selected for every synthesis project. All our catalog peptides are provided with HPLC-MS analyses to confirm the identity and demonstrate the high quality of our peptides.
Not found what you are looking for? Request a Quote for you custom antigen peptide!
Benefits of JPT’s Antigen Peptides
- All peptides are made in Germany
- Bulk orders or custom peptide snythesis upon request
- Synthesis protocols designed to avoid toxic contaminants and side products
- Provision of freeze dried aliquots for enhanced stability
- Proven track record for applications in clinical studies
- Order the connected PepMix™ Peptide Pool with your peptide!
References
References for M. tuberculosis (strain ATCC 25177 / H37Ra) Ag85A 187-195, VYAGAMSGL
References:
Read References with JPT’s Antigen Peptides
M. tuberculosis (strain ATCC 25177 / H37Ra) Ag85A 187-195, VYAGAMSGL has been described in:
Protective immune responses to a recombinant adenovirus type 35 tuberculosis vaccine in two mouse strains: CD4 and CD8 T-cell epitope mapping and role of gamma interferon., Infect Immun, 2007 (PMID: 17526747)
MHC class I-associated peptides derive from selective regions of the human genome., J Clin Invest, 2016 (PMID: 27841757)
Documentation
Documentation for M. tuberculosis (strain ATCC 25177 / H37Ra) Ag85A 187-195, VYAGAMSGL
Properties
Properties of M. tuberculosis (strain ATCC 25177 / H37Ra) Ag85A 187-195, VYAGAMSGL
Properties | Values |
---|---|
Application: | T-cell immunity |
Category: | Antigen Peptides |
Condition / Topic: | Infection |
Layout: | Freeze-dried in glass vial |
Organism: | M. tuberculosis |
Protein Name: | Diacylglycerol acyltransferase/mycolyltransferase |
Purity: | Trial Grade: each peptide purified to > 90% (HPLC/MS) |
Quantification: | No, Yes |
Further Information to M. tuberculosis (strain ATCC 25177 / H37Ra) Ag85A 187-195, VYAGAMSGL
Information | Values |
---|---|
Sequence: | H-VYAGAMSGL-OH |
Specifications: | 9mer peptide as TFA salt |